Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
Top Cited Papers
- 12 February 2009
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 360 (7) , 668-678
- https://doi.org/10.1056/nejmoa0803778
Abstract
Dronedarone is a new antiarrhythmic drug that is being developed for the treatment of patients with atrial fibrillation.Keywords
This publication has 16 references indexed in Scilit:
- Risk Stratification Using T‐Wave Alternans: More Questions Waiting to be AnsweredJournal of Cardiovascular Electrophysiology, 2008
- Increased Mortality after Dronedarone Therapy for Severe Heart FailureNew England Journal of Medicine, 2008
- Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or FlutterNew England Journal of Medicine, 2007
- HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-UpHeart Rhythm, 2007
- Dronedarone: An Emerging Agent with Rhythm‐ and Rate‐Controlling EffectsJournal of Cardiovascular Electrophysiology, 2006
- Dronedarone: A new antiarrhythmic agentDrugs of Today, 2006
- Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999Circulation, 2003
- Chronic and Acute Effects of Dronedarone on the Action Potential of Rabbit Atrial Muscle Preparations: Comparison With AmiodaroneJournal of Cardiovascular Pharmacology, 2002
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001
- Electrophysiological Effects of Dronedarone (SR33589), a Noniodinated Benzofuran Derivative, in the Rabbit HeartCirculation, 1999